Immune Responses to Smallpox Vaccination
Condition: Smallpox VaccineIntervention: Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2006 Category: Research Source Type: clinical trials
Immune Responses to Smallpox Vaccination
Condition: Smallpox VaccineIntervention: Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Active, not recruiting - verified May 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2006 Category: Research Source Type: clinical trials
A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis
Condition: Atopic DermatitisInterventions: Biological: MVA-BN® (IMVAMUNE); Biological: IMVAMUNESponsors: Bavarian Nordic; National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 20, 2006 Category: Research Source Type: clinical trials
A Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy Subjects
Condition: SmallpoxInterventions: Biological: MVA-BN® (IMVAMUNE); Biological: IMVAMUNE; Biological: IMVAMUNE; Biological: IMVAMUNESponsors: Bavarian Nordic; National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2006 Category: Research Source Type: clinical trials
Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.
Condition: SmallpoxIntervention: Biological: IMVAMUNE (MVA-BN)Sponsors: Bavarian Nordic; National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2005 Category: Research Source Type: clinical trials
